Cited by 925TGF-β signaling in diseasesImmune cells in cancerChemokine receptors and signaling

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Open access

Yang, Li, Huang, Jianhua, Ren, Xiubao, Gorska, Agnieszka E., Chytil, Anna, Aakre, Mary, Carbone, David P., Matrisian, Lynn M., Richmond, Ann, Lin, P. Charles, Moses, Harold L.·2008·Cancer Cell

DOI 10.1016/j.ccr.2007.12.004PMC PMC2245859

Open this paper in CoChat — free account Open PDF

Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.12.004

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Endothelial Progenitor Cells
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,388
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citation
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,565
Self-citation
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citation
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,197
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Self-citation

Show all 61 references

Sorted by citations

Items 101–200 of 925

The Role of the Microenvironment in Mammary Gland Development and CancerPreprint
Polyak, K., & Kalluri, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003244 · Cited by 329
Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
Gao, D., Joshi, N., Choi, H., Ryu, S., Hahn, M., Catena, R., Sadik, H., Argani, P., Wagner, P. L., Vahdat, L. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2905 · Cited by 311
Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
Sade-Feldman, M., Kanterman, J., Ish‐Shalom, E., Elnekave, M., Horwitz, E. P., & Baniyash, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.007 · Cited by 306
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Ko, J. S., Rayman, P. A., Ireland, J. L., Swaidani, S., Li, G., Bunting, K. D., Rini, B. I., Finke, J. H., & Cohen, P. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3278 · Cited by 304
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S. C., Lam, W. L., & Bennewith, K. L. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 295
Cancer immunology—analysis of host and tumor factors for personalized medicine
Ogino, S., Galon, J., Fuchs, C. S., & Dranoff, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.122 · Cited by 287
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
Bonde, A.-K., Tischler, V., Kumar, S., Soltermann, A., & Schwendener, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-35 · Cited by 292
MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
Liu, Y., Lai, L., Chen, Q., Song, Y., Xu, S., Ma, F., Wang, X., Wang, J., Yu, H. C., Cao, X., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103505 · Cited by 278
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Dobrolecki, L. E., Airhart, S., Alférez, D., Aparicio, S. A. J. R., Behbod, F., Bentires‐Alj, M., Brisken, C., Bult, C. J., Cai, S., Clarke, R. B., et al. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9653-x · Cited by 272
Epidermal Notch1 Loss Promotes Skin Tumorigenesis by Impacting the Stromal Microenvironment
Demehri, S., Turkoz, A., & Kopan, R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.016 · Cited by 269
Inhibition of Rho-Associated Kinase Signaling Prevents Breast Cancer Metastasis to Human Bone
Liu, S., Goldstein, R. H., Scepansky, E. M., & Rosenblatt, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1541 · Cited by 264
IL-17A Produced by γδ T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
Ma, S., Cheng, Q., Cai, Y., Gong, H., Wu, Y., Xiao, Y., Shi, L., Wu, D., Dong, C., & Liu, H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2534 · Cited by 275
Targeting the transforming growth factor-β signaling pathway in human cancer
Nagathihalli, N. S., & Datta, P. K. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903382609 · Cited by 263
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options
So, J. Y., Ohm, J. E., Lipkowitz, S., & Li, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108253 · Cited by 269
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Salemme, V., Centonze, G., Cavallo, F., Defilippi, P., & Conti, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.610303 · Cited by 262
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Waight, J. D., Hu, Q., Miller, A., Liu, S., & Abrams, S. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027690 · Cited by 247
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
Chiu, D. K., Xu, I. M., Lai, R. K., Tse, A. P., Wei, L. L., Koh, H., Li, L. L., Lee, D., Lo, R. C., Wong, C., et al. (2016) · Hepatology · doi:10.1002/hep.28655 · Cited by 241
Transforming growth factor-β and the hallmarks of cancer
Tian, M., Neil, J. R., & Schiemann, W. P. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.015 · Cited by 254
Transforming growth factor β as regulator of cancer stemness and metastasis
Bellomo, C., Caja, L., & Moustakas, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.255 · Cited by 235
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Filipazzi, P., Huber, V., & Rivoltini, L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1161-9 · Cited by 247
HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
Parker, K. H., Sinha, P., Horn, L. A., Clements, V. K., Yang, H., Li, J., Tracey, K. J., & Ostrand‐Rosenberg, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2347 · Cited by 251
Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E2 and Toll‐like receptor/MyD88 pathways
Echizen, K., Hirose, O., Maeda, Y., & Oshima, M. (2016) · Cancer Science · doi:10.1111/cas.12901 · Cited by 242
CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
Zhang, W., Wang, H., Sun, M., Deng, X., Wu, X., Ma, Y., Li, M., Shuoa, S. M., You, Q., & Miao, L. (2020) · 癌症：英文版 · doi:10.1002/cac2.12010 · Cited by 239
The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells
Taylor, M. A., Parvani, J. G., & Schiemann, W. P. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9181-1 · Cited by 235
On the origin of myeloid-derived suppressor cells
Millrud, C. R., Bergenfelz, C., & Leandersson, K. (2016) · Oncotarget · doi:10.18632/oncotarget.12278 · Cited by 243
TGF- Biology in Mammary Development and Breast CancerPreprint
Moses, H. L., & Barcellos‐Hoff, M. H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003277 · Cited by 234
Self-citation
The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Raccosta, L., Fontana, R., Maggioni, D., Lanterna, C., Villablanca, E. J., Paniccia, A., Musumeci, A. G., Chiricozzi, E., Trincavelli, M. L., Daniele, S., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130440 · Cited by 234
Neutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils
Yu, P., Huang, Y., Han, Y., Lin, L., Sun, W., Rabson, A. B., Wang, Y., & Shi, Y. (2016) · Oncogene · doi:10.1038/onc.2016.217 · Cited by 227
Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis
Chiodoni, C., Colombo, M. P., & Sangaletti, S. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9221-8 · Cited by 221
High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors.
Ojalvo, L., King, W., Cox, D., & Pollard, J. (2009) · American Journal of Pathology · doi:10.2353/ajpath.2009.080676 · Cited by 223
Phenotype, development, and biological function of myeloid-derived suppressor cells
Zhao, Y., Wu, T., Shao, S., Shi, B., & Zhao, Y. X. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1004983 · Cited by 220
Unique pattern of neutrophil migration and function during tumor progression
Patel, S., Fu, S., Mastio, J., Dominguez, G. A., Purohit, A., Kossenkov, A. V., Lin, C., Alicea-Torres, K. M., Sehgal, M., Nefedova, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0229-5 · Cited by 222
Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
Li, B., Garstka, M. A., & Li, Z. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.11.014 · Cited by 223
Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
Yu, J., Wang, Y., Fang, Y., Zhang, P., Li, H., Zhao, H., Yan, C., Fan, Y. L., & Ren, X. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400833 · Cited by 222
Self-citation
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Chew, V., Toh, H. C., & Abastado, J. (2012) · Journal of Oncology · doi:10.1155/2012/608406 · Cited by 224
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
Welte, T., Kim, I. S., Tian, L. H., Gao, X., Wang, H., Li, J., Holdman, X. B., Herschkowitz, J. I., Pond, A. C., Xie, G., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3355 · Cited by 217
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
Bruno, A., Mortara, L., Baci, D., Noonan, D. M., & Albini, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00771 · Cited by 223
Two Faces of TGF-Beta1 in Breast Cancer
Zarzynska, J. M. (2014) · Mediators of Inflammation · doi:10.1155/2014/141747 · Cited by 213
Emerging strategies for combination checkpoint modulators in cancer immunotherapy
Popović, A., Jaffee, E. M., & Zaidi, N. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120775 · Cited by 209
Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression
Wendt, M. K., Tian, M., & Schiemann, W. P. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1199-1 · Cited by 215
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
Teixeira, A. F., ten Dijke, P., & Zhu, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00605 · Cited by 216
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
Pawig, L., Klasen, C., Weber, C., Bernhagen, J., & Noels, H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00429 · Cited by 229
Monocytes and Macrophages in Cancer: Development and Functions
Richards, D. M., Hettinger, J., & Feuerer, M. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0123-x · Cited by 215
Myeloid‐derived suppressor cells in cancer: recent progress and prospects
Khaled, Y. S., Ammori, B. J., & Elkord, E. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.29 · Cited by 214
Leukocytes in Mammary Development and CancerPreprint
Coussens, L. M., & Pollard, J. W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003285 · Cited by 214
Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
Patsialou, A., Wyckoff, J. B., Wang, Y., Goswami, S., Stanley, E. R., & Condeelis, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1868 · Cited by 207
Therapeutic targeting of myeloid-derived suppressor cells
Ugel, S., Delpozzo, F., Desantis, G., Papalini, F., Simonato, F., Sonda, N., Zilio, S., & Bronte, V. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.014 · Cited by 207
Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast
Hu, M. S., Peluffo, G., Chen, H., Gelman, R. S., Schnitt, S. J., & Polyák, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813306106 · Cited by 205
Signaling pathways involved in MDSC regulation
Trikha, P., & Carson, W. E. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.003 · Cited by 207
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Fuxe, J., & Karlsson, M. C. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.004 · Cited by 198
Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
Achyut, B. R., & Yang, H. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.048 · Cited by 203
The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
Vasievich, E. A., & Huang, L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1004228 · Cited by 199
Cancer Vaccines, Adjuvants, and Delivery Systems
Paston, S. J., Brentville, V. A., Symonds, P., & Durrant, L. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627932 · Cited by 200
The TGF-β Paradox in Human Cancer: An Update
Tian, M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/14796694.5.2.259 · Cited by 200
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
Najjar, Y. G., Rayman, P. A., Jia, X., Pavicic, P. G., Rini, B. I., Tannenbaum, C. S., Ko, J. S., Haywood, S., Cohen, P. A., Hamilton, T. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1823 · Cited by 196
Tumor microenvironment: a main actor in the metastasis process
Spano, D., & Zollo, M. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9457-5 · Cited by 199
Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene
Stairs, D. B., Bayne, L. J., Rhoades, B., Vega, M. E., Waldron, T. J., Kalabis, J., Klein–Szanto, A. J., Lee, J., Katz, J. P., Diehl, J. A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.007 · Cited by 196
Cancer Dissemination—Lessons from Leukocytes
Madsen, C. D., & Sahai, E. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.013 · Cited by 203
Molecular Pathways: Targeting the TGF-β Pathway for Cancer Therapy
Smith, A., Robin, T. P., & Ford, H. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3224 · Cited by 192
The relevance of EMT in breast cancer metastasis: Correlation or causality?
Bill, R., & Christofori, G. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.002 · Cited by 192
Interplay between inflammation and cancer
Piotrowski, I., Kulcenty, K. I., & Suchorska, W. M. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.04.004 · Cited by 192
Stromally Derived Lysyl Oxidase Promotes Metastasis of Transforming Growth Factor-β–Deficient Mouse Mammary Carcinomas
Pickup, M. W., Laklai, H., Acerbi, I., Owens, P., Gorska, A. E., Chytil, A. M., Aakre, M. E., Weaver, V. M., & Moses, H. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0012 · Cited by 187
Self-citation
Molecular pathways and targets in cancer-related inflammation
Mantovani, A., Garlanda, C., & Allavena, P. (2010) · Annals of Medicine · doi:10.3109/07853890903405753 · Cited by 182
Evolution and dynamics of pancreatic cancer progression
Yachida, S., & Iacobuzio–Donahue, C. A. (2013) · Oncogene · doi:10.1038/onc.2013.29 · Cited by 185
Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
Sterling, J. A. R., Edwards, J., Martin, T. J., & Mundy, G. R. (2010) · Bone · doi:10.1016/j.bone.2010.07.015 · Cited by 183
M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
Zhou, H., Roy, S., Cochran, E. D., Zouaoui, R., Chu, C. L., Duffner, J. L., Zhao, G., Smith, S., Galcheva-Gargova, Z., Karlgren, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021106 · Cited by 182
Role of the VEGF/VEGFR Axis in Cancer Biology and Therapy
Rapisarda, A., & Melillo, G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-386503-8.00006-5 · Cited by 186
Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
Schmid, M. C., & Varner, J. A. (2010) · Journal of Oncology · doi:10.1155/2010/201026 · Cited by 191
Myeloid-Derived Suppressor Cells Evolve during Sepsis and Can Enhance or Attenuate the Systemic Inflammatory Response
Brudecki, L. E., Ferguson, D. A., McCall, C. E., & Gazzar, M. E. (2012) · Infection and Immunity · doi:10.1128/iai.00239-12 · Cited by 179
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Fluck, M. M., & Schaffhausen, B. S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00009-09 · Cited by 186
Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression
Gao, D., Nolan, D., McDonnell, K., Vahdat, L. T., Benezra, R., Altorki, N. K., & Mittal, V. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.05.001 · Cited by 181
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
Kitamura, T., Fujishita, T., Loetscher, P., Révész, L., Hashida, H., Kizaka‐Kondoh, S., Aoki, M., & Taketo, M. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002372107 · Cited by 180
Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
Yang, Z., Zhang, B., Li, D., Lv, M., Huang, C., Shen, G., & Huang, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008922 · Cited by 183
Subsets, expansion and activation of myeloid-derived suppressor cells
Ribechini, E., Greifenberg, V., Sandwick, S. J., & Lutz, M. B. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0151-4 · Cited by 176
Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis
Safarzadeh, E., Orangi, M., Mohammadi, H., Babaie, F., & Baradaran, B. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26075 · Cited by 177
Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis
Yi, H., Guo, C., Yu, X., Zuo, D., & Wang, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200086 · Cited by 177
KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma
Lu, Y., Qin, H., Jiang, B., Lu, W., Hao, J., Cao, W., Du, L., Chen, W., Zhao, X., & Guo, H. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.014 · Cited by 178
Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review
Perlikos, F., Harrington, K. J., & Syrigos, K. N. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.12.007 · Cited by 174
Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
Diaz-Montero, C. M., Finke, J. H., & Montero, A. J. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.003 · Cited by 180
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Jung, K., Heishi, T., Khan, O. F., Kowalski, P. S., Incio, J., Rahbari, N. N., Chung, E., Clark, J. W., Willett, C. G., Luster, A. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93182 · Cited by 164
Transmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
Hu, X., Li, B., Li, X., Zhao, X., Wan, L., Lin, G., Yu, M., Wang, J., Jiang, X., Wei, F., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203195 · Cited by 172
Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
Li, Z., Wang, Y., Shen, Y., Qian, C., Oupický, D., & Sun, M. (2020) · Science Advances · doi:10.1126/sciadv.aaz9240 · Cited by 173
Camouflage and sabotage: tumor escape from the immune system
Poschke, I. C., Mougiakakos, D., & Kiessling, R. W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1012-8 · Cited by 168
Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
Díaz‐Cano, S. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021951 · Cited by 179
TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
Drabsch, Y., & ten Dijke, P. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9217-1 · Cited by 172
Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications
Lau, E. Y.-T., Ho, N. P. Y., & Lee, T. K. (2017) · Stem Cells International · doi:10.1155/2017/3714190 · Cited by 174
CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer
Korbecki, J., Kupnicka, P., Chlubek, M., Gorący, J., Gutowska, I., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042168 · Cited by 173
Role of myeloid cells in tumor angiogenesis and growth
Shojaei, F., Zhong, C., Wu, X., Yu, L., & Ferrara, N. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.06.003 · Cited by 169
CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
Mousavi, A. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.11.007 · Cited by 171
Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
Tu, S. P., Jin, H., Shi, J. D., Zhu, L. M., Suo, Y., Lü, G., Liu, A., Wang, T. C., & Yang, C. S. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0247 · Cited by 167
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 173
Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
Tsubakihara, Y., & Moustakas, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113672 · Cited by 160
Metastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 166
Intertwined regulation of angiogenesis and immunity by myeloid cells
Rivera, L. B., & Bergers, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.005 · Cited by 160
Osteopontin Shapes Immunosuppression in the Metastatic Niche
Sangaletti, S., Tripodo, C., Sandri, S., Torselli, I., Vitali, C., Ratti, C., Botti, L., Burocchi, A., Porcasi, R., Tomirotti, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3334 · Cited by 160
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF- through a PGE2-dependent mechanisms
Neil, J. R., JOHNSON, K. M., Nemenoff, R. A., & Schiemann, W. P. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn202 · Cited by 159
Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Bai, J., Gao, Z., Li, X., Dong, L., Han, W., & Nie, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22690 · Cited by 159
Enhancing Tumor T Cell Infiltration to Enable Cancer Immunotherapy
Zhang, J., Endres, S., & Kobold, S. (2019) · Immunotherapy · doi:10.2217/imt-2018-0111 · Cited by 159
TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
Pang, Y., Gara, S. K., Achyut, B. R., Li, Z., Yan, H. H., Day, C., Weiss, J. M., Trinchieri, G., Morris, J. C., & Li, Y. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0527 · Cited by 160

Authors: Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
Affiliations: Vanderbilt University (US)
Corresponding author: Moses, Harold L.
ORCID: Huang, Jianhua
Ren, Xiubao
Gorska, Agnieszka E.
Carbone, David P.
Matrisian, Lynn M.
Richmond, Ann
Moses, Harold L.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2008-01
Volume: 13
Issue: 1
Pages: 23-35
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.12.004
PMC: PMC2245859
OpenAlex: W2130870648
Cited by: 918
References: 61
Citations by year: 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
FWCI: 29.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2024 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK6 BX005225)
Vanderbilt University
National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords: TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks